1522 -- A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable. | Poliscope

A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.

1522

118th Congress

In Committee

A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable.

Legislative Progress

✓

Introduced

2

Committee

3

Floor Vote

4

Other Chamber

5

Enacted

Introduced

May 10, 2023

Latest Action

May 10, 2023

Primary Sponsor

Roger MarshallRepublican(KS)

Momentum (last 30 days)

0

score

0 actions · 0 new cosponsors · 0 votes

Speed vs cohort

0pct

0d open

vs 5,649 other S bills in the 118th — cohort avg 33d

Summary

No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.

Actions (2)

May 10, 2023

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

May 10, 2023

Introduced in Senate

Committees

Committee	Chamber	Activity	Date
Health, Education, Labor, and Pensions Committee	Senate	Referred To	May 10, 2023

Text Versions

Version	Date	Links
Introduced in Senate	May 10, 2023	XML

Similar Bills (AI)

Bills with similar content found using semantic analysis.

119th

80%

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

118th

71%

A bill to require the Secretary of Labor to conduct a study on the fiduciary duties of pharmacy benefit managers.

119th

71%

Biosimilar Red Tape Elimination Act

Sources: Congress.gov